Nonclinical safety testing of RNA vaccines

Abstract

In this chapter, we first consider the overall goal of nonclinical safety testing during drug development and have a brief overview of its regulatory background. We then discuss some basic requirements of safety/ toxicity testing before concentrating on the safety testing of RNA vaccines and developing a sample RNA vaccine safety testing program.